Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A website has been established for a Lovenox price-fixing class action lawsuit which recently saw the certification of a Class of indirect purchasers of the anticoagulant.
The website provides information regarding the class action which is scheduled to go to trial unless a settlement can be reached.
While the website is live, it is not accepting claims yet. Top Class Actions will provide claim filing instructions as soon as they become available.
Meanwhile, viewers will receive an email notice when this article is updated with more information by using a free Top Class Actions account and clicking the “Follow Article” button at the top of the post.
Plaintiffs in the Lovenox class action lawsuit motioned for Class certification in November and were subsequently granted certification by the court.
The certified Class includes individuals or entities who bought or provided payment for Lovenox or enoxaparin (the generic form of the drug) between Sept. 21, 2011 and Sept. 30, 2015.
The Class includes hospitals, third party payors, and people without insurance from the following states: Arizona, Arkansas, California, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin.
Class Members had until Dec. 19, 2019 to exclude themselves from the Class or object to the Lovenox class action lawsuit.
Lovenox, and the generic form enoxaparin, are blood thinning medications used to manage the risk of blood clots. The medication is particularly prescribed to people who are at risk for developing clots in the legs through a condition known as deep vein thrombosis.
According to plaintiffs in the Lovenox class action lawsuit, manufacturers Momenta Pharmaceuticals Inc. and Sandoz Inc. conspired together to artificially increase the cost of the medications. The companies allegedly achieved this by suppressing other generic forms of Lovenox – meaning that the only options for the medication were Lovenox or the generic enoxaparin.
In 2003, Momenta and Sandoz reportedly reached an agreement under which the companies would split Sandoz’s profits from generic enoxaparin. However, according to the plaintiffs, the terms of this agreement were only in effect if Sandoz was the only company to sell the generic drug.
In order to suppress the competition, Momenta allegedly secured a patent on the quality test used in the production of enoxaparin. This reportedly meant that no other companies could manufacture the generic medication without infringing on the patent.
Other companies attempted to sell the generic medication or patent the testing practice but were allegedly manipulated or sued by Momenta until they backed off – ensuring the company’s control of the market.
As a result of the agreement and subsequent suppression of competition, Momenta and Sandoz reportedly secured a monopoly which allowed them to increase the price of the medication. Plaintiffs in the Lovenox class action lawsuit claim that indirect purchasers of the products were financially harmed by the alleged price-fixing scheme.
Did you take Lovenox or the generic form of the drug, enoxaparin? Share your experiences in the comment section below.
Plaintiffs and the recently certified Class are represented by Brendan P. Glackin, Mark P. Chalos, Dean M. Harvey, Bruce W. Leppla, Katherine L. Benson, John Tate Spragens and Adam Gitlin of Lieff Cabraser Heimann & Bernstein LLP.
The Lovenox Antitrust Class Action Lawsuit is The Hospital Authority of Metropolitan Government of Nashville and Davidson County Tennessee, et al. v. Momenta Pharmaceuticals Inc., et al., Case No. 3:15-cv-01100, in the U.S. District Court for the Middle District of Tennessee.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
108 thoughts onLovenox Price-Fixing Class Action Website Is Live
Add me please I had this when I had my total knee replacement
Add me please.
Between 2011 and 2015, I have taken Lovenox many times because of my clotting issue. They put me on it before surgical procedures and after. The cost was and IS atrocious!
I actually have 4 doses in front of me for my upcoming dentist appt. Taking me off Coumadin and putting me on the Lovenox shots. Cost was $235.99!!!!
Add me please.
I used Lovenox between 2010 and 2013 for 3 weeks each time I was put on it the medication and it was expensive.
Add me please. Used medications in 2011 for 4-6 weeks post surgery.
My husband has been on Lovenox numerous times for a chronic condition that requires surgery often. They used Lovenox to bridge him while hes off the coumadin. So please add us to the claim.
My husband did in early 2000 for 6 months and hospital stay
I took this shot for weeks after having 2 surgeries.
Add me please
add me
I had to inject myself times a day for over years and the medicine was sky high to be nothing more than a blood thinner. Companies need to stop being shelter from prosecution for their deliberate crimes. This is a life or death medication. Who knows just how many people these greedy $&$&$ killed!
3 times a day I meant